Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Meni Girshengorn"'
Autor:
Noam Cohen, Irit Simon, Ophir Hazan, Arnon Tal, Hanan Tzadok, Lilach Levin, Meni Girshengorn, Lilach Cherry Mimran, Niva Natan, Tzadok Baruhi, Alon Ben David, Osnat Rosen, Shlomo Shmaya, Sarah Borni, Noa Cohen, Edith Lupu, Adi Kedmi, Orian Zilberman, Avital Jayson, Arik Monash, Eyal Dor, Eran Diamant, Michael Goldvaser, Inbar Cohen-Gihon, Ofir Israeli, Shirley Lazar, Ohad Shifman, Adi Beth-Din, Anat Zvi, Ziv Oren, Arik Makovitzki, Elad Lerer, Avishai Mimran, Einat Toister, Ran Zichel, Yaakov Adar, Eyal Epstein
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
The COVID-19 pandemic has led to high global demand for vaccines to safeguard public health. To that end, our institute has developed a recombinant viral vector vaccine utilizing a modified vesicular stomatitis virus (VSV) construct, wherein the G pr
Externí odkaz:
https://doaj.org/article/decca5fe62ee475690287d8e70308a6f
Autor:
Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Eyal Dor, Lilach Levin, Meni Girshengorn, Niva Natan, Shira Chapman, Shlomo Shmaya, Eyal Epstein, Yaakov Adar, Ran Zichel, Yakir Ophir, Eran Diamant
Publikováno v:
Vaccines, Vol 12, Iss 4, p 374 (2024)
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than seven million deaths worldwide. To reduce viral spread, the Israel Institute for Biological Research (IIBR) developed and produce
Externí odkaz:
https://doaj.org/article/7396402146a4420489f34910524eb755
Autor:
Adva Mechaly, Eran Diamant, Ron Alcalay, Alon Ben David, Eyal Dor, Amram Torgeman, Ada Barnea, Meni Girshengorn, Lilach Levin, Eyal Epstein, Ariel Tennenhouse, Sarel J. Fleishman, Ran Zichel, Ohad Mazor
Publikováno v:
Antibodies, Vol 11, Iss 1, p 21 (2022)
Botulinum neurotoxin type E (BoNT/E), the fastest acting toxin of all BoNTs, cleaves the 25 kDa synaptosomal-associated protein (SNAP-25) in motor neurons, leading to flaccid paralysis. The specific detection and quantification of the BoNT/E-cleaved
Externí odkaz:
https://doaj.org/article/797ceaec67d04932a171fe9845595a57
Autor:
Arik Makovitzki, Avital Jayson, Ziv Oren, Elad Lerer, Yaron Kafri, Eyal Dor, Lilach Cherry, Hanan Tzadok, Lilach Levin, Ophir Hazan, Irit Simon, Arnon Tal, Meni Girshengorn, Osnat Rosen
Publikováno v:
BioTech, Vol 10, Iss 4, p 25 (2021)
The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases the need for a rapid development of efficient vaccines. Among other vaccines in clinical trials, a recombinant VSV-∆G-spike vaccine was developed
Externí odkaz:
https://doaj.org/article/9fdb0f0bb6304d2198df94de3a3b3750
Autor:
Elad Lerer, Ziv Oren, Yaron Kafri, Yaakov Adar, Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Rona Levy, Eyal Dor, Eyal Epstein, Lilach Levin, Meni Girshengorn, Niva Natan, Ran Zichel, Arik Makovitzki
Publikováno v:
BioTech, Vol 10, Iss 4, p 22 (2021)
This study reports a highly efficient, rapid one-step purification process for the production of the recombinant vesicular stomatitis virus-based vaccine, rVSV-∆G-spike (rVSV-S), recently developed by the Israel Institute for Biological Research (I
Externí odkaz:
https://doaj.org/article/ec8d02d46a0f4563872ec5210a222009
Autor:
null Avital Jayson, null Michael Goldvaser, null Eyal Dor, null Arik Monash, null Lilach Levin, null Lilach Cherry, null Edith Lupu, null Niva Natan, null Meni Girshengorn, null Eyal Epstein, null Osnat Rosen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e88f271a24f62e6552de7d762598eac2
https://doi.org/10.1002/btpr.3277/v2/response1
https://doi.org/10.1002/btpr.3277/v2/response1
Autor:
Avital Jayson, Michael Goldvaser, Eyal Dor, Arik Monash, Lilach Levin, Lilach Cherry, Edith Lupu, Niva Natan, Meni Girshengorn, Eyal Epstein, Osnat Rosen
Publikováno v:
Biotechnology progressREFERENCES. 38(5)
The Ambr15 system is an automated, high-throughput bioreactor platform which comprises 24 individually controlled, single-use stirred-tank reactors. This system plays a critical role in process development by reducing reagent requirements and facilit
Autor:
Osnat Rosen, Avital Jayson, Michael Goldvaser, Eyal Dor, Arik Monash, Lilach Levin, Lilach Cherry, Edith Lupu, Niva Natan, Meni Girshengorn, Eyal Epstein
Publikováno v:
Biotechnology and bioengineering. 119(7)
To face the coronavirus disease 2019 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, our institute has developed the rVSV-ΔG-spike vaccine, in which the glycoprotein of vesicular stomatitis virus (VSV) was
Autor:
Ziv Oren, Yaron Kafri, Ophir Hazan, Meni Girshengorn, Osnat Rosen, Avital Jayson, Arik Makovitzki, Lilach Levin, Lilach Cherry, Eyal Dor, Elad Lerer, Arnon Tal, Irit Simon, Hanan Tzadok
Publikováno v:
BioTech, Vol 10, Iss 25, p 25 (2021)
The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases the need for a rapid development of efficient vaccines. Among other vaccines in clinical trials, a recombinant VSV-∆G-spike vaccine was developed
Autor:
Rona Levy, Edith Lupu, Meni Girshengorn, Yaakov Adar, Ran Zichel, Eyal Dor, Eyal Epstein, Yaron Kafri, Arik Makovitzki, Ziv Oren, Niva Natan, Einat Toister, Elad Lerer, Arik Monash, Lilach Cherry, Lilach Levin
Publikováno v:
BioTech, Vol 10, Iss 22, p 22 (2021)
BioTech
Volume 10
Issue 4
BioTech
Volume 10
Issue 4
This study reports a highly efficient, rapid one-step purification process for the production of the recombinant vesicular stomatitis virus-based vaccine, rVSV-∆G-spike (rVSV-S), recently developed by the Israel Institute for Biological Research (I